X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-04-11 | BCEL | Orwin John A | Pres, CEO | P - Purchase | $0.01 | +1 | 77,542 | 0% | +$0 | ||||||
2024-04-01 | BCEL | Serafini Tito | Dir | S - Sale | $0.07 | -20,788 | 322,511 | -6% | -$1,455 | ||||||
2023-09-01 | BCEL | Orwin John A | Pres, CEO | S - Sale | $0.37 | -22,951 | 77,541 | -23% | -$8,597 | ||||||
2023-09-01 | BCEL | Serafini Tito | Dir | S - Sale | $0.37 | -8,393 | 343,299 | -2% | -$3,144 | ||||||
2023-09-01 | BCEL | Courtney Phillips | GC, Secretary | S - Sale | $0.37 | -7,061 | 50,431 | -12% | -$2,645 | ||||||
2023-10-19 | BCEL | Baker Bros. Advisors LP | Former 10% Owner | S - Sale | $0.40 | -274,739 | 2,971,128 | -8% | -$110,582 | ||||||
2023-08-02 | BCEL | Serafini Tito | Chief Strategy Officer | S - Sale | $0.95 | -5,487 | 351,692 | -2% | -$5,225 | ||||||
2023-08-02 | BCEL | Cross Herb | CFO | S - Sale | $0.95 | -5,487 | 72,817 | -7% | -$5,225 | ||||||
2023-08-02 | BCEL | Gould Stephen E | Chief Scientific Officer | S - Sale | $0.95 | -4,076 | 28,424 | -13% | -$3,881 | ||||||
2023-08-02 | BCEL | Courtney Phillips | GC, Secretary | S - Sale | $0.95 | -4,076 | 57,492 | -7% | -$3,881 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |